Neutralising HIV with antibodies; Malaria breakthrough; Second biopsy … – Insidermedicine
Neutralising HIV with antibodies; Malaria breakthrough; Second biopsy ... Insidermedicine From California, researchers at Caltech have found a way to introduce antibodies capable of neutralizing HIV into mice. While the current research demonstrates an effective approach to HIV prevention, it remains to be seen whether this approach can be ... |
We Found It on Watch Instantly: Wesley Snipes in Game of Death – Grantland (blog)
We Found It on Watch Instantly: Wesley Snipes in Game of Death Grantland (blog) It's a game of firing a gun at your brain; death is just a frequent result. Or maybe death is the currency of this game? Is poker a game of chips or of cards? Is the film saying the very act of living is a game of death? Or perhaps going to Detroit, ... |
New approach to graft-versus-host treatment results in improvement for some … – EurekAlert (press release)
New approach to graft-versus-host treatment results in improvement for some ... EurekAlert (press release) 1 issue of the New England Journal of Medicine, involved allogeneic (donor) stem cell transplant patients with chronic graft-versus-host disease (GVHD), a multi-system inflammatory condition that arises when donor immune system cells launch an attack ... |
Cách chữa trị bệnh thiếu máu huyết tán beta thalassemia – VOA Tiếng Việt
Cách chữa trị bệnh thiếu máu huyết tán beta thalassemia VOA Tiếng Việt Gần đây hơn, do chuẩn bị bịnh nhân tốt hơn và do kỹ thuật matching tế bào (high resolution HLA typing, phân loại HLA tế bào phân giải cao), bác sĩ có thể chọn những donors không phải là bà con, mà vẫn có kết quả tương tự. Người ta cũng dùng tế bào gốc ... |
Gardner Russo Gardner Lowers Abbott Labs Shares, Starts Medtronic and Pfizer … – Wall St. Cheat Sheet
Gardner Russo Gardner Lowers Abbott Labs Shares, Starts Medtronic and Pfizer ... Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Medtronic Inc. (NYSE:MDT): On 06/30/2011, Gardner Russo Gardner ... |
Researchers Examine Role of Inflammatory Mechanisms in a Healing Heart Opening … – Newswise (press release)
Researchers Examine Role of Inflammatory Mechanisms in a Healing Heart Opening ... Newswise (press release) “Defining the role of the inflammasome in the response to injury in the heart and the possibility to intervene opens a new area of investigation for the prevention and treatment of heart failure following a heart attack,” said Antonio Abbate, MD, ... |
Updated: Presumed consent ‘would fail to drive up’ organ donor numbers, claims … – WalesOnline
Updated: Presumed consent 'would fail to drive up' organ donor numbers, claims ... WalesOnline In the event of something going wrong, heaven forbid, we could end up with a negative situation in which the process that is adopted in Wales fundamentally undermines confidence in organ donation altogether.” Conservative health minister Anne Milton ... MPs debate Organ Donation |
Spindle Antibodies – Drug Discovery & Development
Spindle Antibodies Drug Discovery & Development GeneTex, a leading manufacturer of antibodies and antibody-related reagents, has announced that they will be launching a new line of antibodies against Hice1 and Hec1. Both of these targets are key players in spindle assembly. ... |
New devices to treat heart failure approved by FDA – DigitalJournal.com
 DigitalJournal.com | New devices to treat heart failure approved by FDA DigitalJournal.com By KJ Mullins. New implant devices from Boston Scientific has been granted FDA approval. The INCEPTA, ENERGEN and PUNCTUA™cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) are now ... Boston Scientific Announces FDA Approval and First Implant for New Devices to ... Boston Scientific gets FDA OK for three defibrillators Boston Scientific's Three Heart Defibrillators Get FDA Approval |
Volume Loss as the Predominant Determinant of Ultimate Renal Function after PN – Renal and Urology News
Volume Loss as the Predominant Determinant of Ultimate Renal Function after PN Renal and Urology News The objectives of partial nephrectomy (PN) for kidney cancer are to optimize cancer control by obtaining negative margins while preserving as much renal function as possible. Most conventional PNs are facilitated by temporary clamping of the renal ... |